Contract 75D30121C10168
The Medical University Of South Carolina · Department Of Health And Human Services · December 17, 2025
The Medical University Of South Carolina was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on December 17, 2025 for $995,000 of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. It uses cost no fee contract pricing. If all options are exercised, the contract could reach $9.86 million.
Contract details
- PIID
- 75D30121C10168
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- First action
- December 17, 2025
Description
TUBERCULOSIS TRIALS AND CONSORTIUM
Modification timeline
-
December 17, 2025Mod P00008 · Exercise An Option$5.62M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30121C10168?
Contract 75D30121C10168 is a federal contract awarded to The Medical University Of South Carolina by Department Of Health And Human Services on December 17, 2025 for $995,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75D30121C10168?
The Medical University Of South Carolina won contract 75D30121C10168 from Department Of Health And Human Services.
How much is contract 75D30121C10168 worth?
Contract 75D30121C10168 has obligated $995,000 to date, with a total potential value of $9.86 million if all options are exercised.